Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
(NASDAQ: FULC) Delayed: 3.70 --0 (-0%)
Previous Close $3.70    52 Week High $ 
Open $3.73    52 Week Low $ 
Day High $3.73    P/E N/A 
Day Low $3.67    EPS $ 
Volume 1,582,528